Video Latest - ecancer

WIN Symposium 2014: Breakthrough biomarker investigations and combination therapies

Dr John Mendelsohn, Dr Razelle Kurzrock, Dr Mace Rothenberg

6 May 2014

Work and history of the Kidney Cancer Association

Carrie Konosky - Vice President of Development & Public Affairs, Kidney Cancer Association, Chicago, USA

6 May 2014

Intratumour heterogeneity in renal and lung cancer

Prof Charles Swanton - CRUK London Research Institute and UCL, London, UK

6 May 2014

High levels of mutated p53 indicate metastatic phenotype

Dr Guillermina Lozano - The University of Texas MD Anderson Cancer Center, Houston, USA

5 May 2014

Phase II trial shows dacomitinib benefits a subgroup of patients with head and neck cancer

Dr Byoung Chul Cho - Yonsei University College of Medicine, Seoul, Republic of Korea

1 May 2014

"Exciting" implications of bemacyclib study in the treatment of breast cancer

Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA

1 May 2014

Impact of the liver environment upon the efficacy of induction therapy

Dr Frederic Bibeau - Institut regional du Cancer, Montpellier, France

1 May 2014

Study identifies new strategy to overcome breast cancer resistance to HER2-targeted therapies

Dr Joan Garrett - Vanderbilt University Medical Center, Nashville, USA

1 May 2014

Benefits found for lung cancer patients with high levels of PD-L1 with MK-3475 treatment

Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA

1 May 2014

Promising research on the use of palbociclib in the treatment of breast cancer

Dr Richard Finn - Ronald Reagan UCLA Medical Center, Los Angeles, USA

1 May 2014

Role of genomics in assessing risk, especially in ovarian cancer

Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA

1 May 2014

Targeted Anti-cancer Therapies (TAT) conference roundup

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

22 Apr 2014

Video